Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines-Reference-Cited by-同舟云学术

Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines

Published:2016-06 Issue:6 Volume:105 Page:1891-1900
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Zhang Ti,Cai Shuang,Groer Chad,Forrest Wai Chee,Yang Qiuhong,Mohr Eva,Douglas Justin,Aires Daniel,Axiak-Bechtel Sandra M.,Selting Kimberly A.,Swarz Jeffrey A.,Tate Deborah J.,Bryan Jeffrey N.,Forrest M. Laird

Funder

National Institute of Health

Kansas Bioscience Authority

Kansas EPSCoR

HylaPharm LLC

NIH Shared Instrumentation

NSF Major Research Instrumentation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference57 articles.

1. Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer;Taylor;J Clin Oncol,1994

2. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial;Rosell;Ann Oncol,2002

3. Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis;Montagnani;Gastric Cancer,2011

4. Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients;Misset;Ann Oncol,2001

5. Cisplatin- vs. oxaliplatin-based radiosensitizing chemotherapy for squamous cell carcinoma of the esophagus: a comparison of two preoperative radiochemotherapy regimens;Fakhrian;Strahlenther Onkol,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viscoelasticity microenvironment constructed by self-crosslinking hyaluronan hybrid hydrogels regulates chondrogenic differentiation of mesenchymal stem cells;Composites Part B: Engineering;2023-08

2. Application of Biocompatible Drug Delivery Nanosystems for the Treatment of Naturally Occurring Cancer in Dogs;Journal of Functional Biomaterials;2022-08-07

3. Nanotechnology and Animal Health;Pharmaceutical Nanotechnology;2021-03-12

4. Intratumoral Cancer Chemotherapy with a Carrier-Based Immunogenic Cell-Death Eliciting Platinum (IV) Agent;Molecular Pharmaceutics;2020-09-25

5. Repurposing biodegradable tissue engineering scaffolds for localized chemotherapeutic delivery;Journal of Biomedical Materials Research Part A;2020-02-03